Sustained Treatment Effect of Spinal Cord Stimulation in Painful Diabetic Peripheral Neuropathy: 24-Month Follow-up of a Prospective Two-Center Randomized Controlled Trial
Autor: | Nicolaas C. Schaper, Rachel Slangen, Alfons G. H. Kessels, Maarten van Kleef, Catharina G. Faber, Elbert A.J. Joosten, Carmen D. Dirksen, Robert van Dongen, Maarten van Beek |
---|---|
Přispěvatelé: | Anesthesiology, EMGO - Musculoskeletal health, Interne Geneeskunde, MUMC+: KIO Kemta (9), Epidemiologie, Anesthesiologie, RS: CAPHRI School for Public Health and Primary Care, RS: CAPHRI - R2 - Creating Value-Based Health Care, RS: MHeNs - R3 - Neuroscience, RS: MHeNs - R1 - Cognitive Neuropsychiatry and Clinical Neuroscience, Klinische Neurowetenschappen |
Rok vydání: | 2015 |
Předmět: |
Adult
Male medicine.medical_specialty Randomization Endocrinology Diabetes and Metabolism Stimulation law.invention Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18] Randomized controlled trial Diabetic Neuropathies law Diabetes mellitus Internal Medicine medicine Humans Prospective Studies Prospective cohort study PDPN Aged Pain Measurement Advanced and Specialized Nursing Spinal Cord Stimulation business.industry Middle Aged medicine.disease Surgery Peripheral neuropathy Treatment Outcome Anesthesia Observational study Female business Follow-Up Studies |
Zdroj: | Beek, M, Slangen, R, Schaper, N C, Faber, C G, Joosten, E A, Dirksen, C D, van Dongen, R T, Kessels, A G H & van Kleef, M 2015, ' Sustained Treatment Effect of Spinal Cord Stimulation in Painful Diabetic Peripheral Neuropathy: 24-Month Follow-up of a Prospective Two-Center Randomized Controlled Trial ', Diabetes Care, vol. 38, no. 9, pp. E132-E134 . https://doi.org/10.2337/dc15-0740 Diabetes Care, 38(9), E132-E134. American Diabetes Association Inc. Diabetes Care, 38(9), e132-e134. American Diabetes Association Diabetes Care, 38, 9, pp. e132-4 Diabetes Care, 38, e132-4 |
ISSN: | 0149-5992 |
DOI: | 10.2337/dc15-0740 |
Popis: | Spinal cord stimulation (SCS) has been demonstrated to serve as a successful second-line treatment modality for painful diabetic peripheral neuropathy (PDPN), as documented in two randomized clinical trials (RCTs) (1,2). Besides the fact that these two RCTs demonstrate a pain-relieving effect for a period of 6 months after the start of SCS treatment, only small observational studies suggest a long-term sustained effect in PDPN (3–5). In this article, we present the 24-month follow-up data of our recently published RCT in Diabetes Care (1). Thirty-six patients were enrolled in this study, and after randomization, 22 patients with PDPN in the lower limbs (15 male, mean age 57.1 years [SD 12.4], years of PDPN 6.0 [SD 5.1]) were assigned to the SCS group. A 2-week trial stimulation was performed to evaluate sufficient pain relief. After 6 … |
Databáze: | OpenAIRE |
Externí odkaz: |